Live Breaking News & Updates on Bnt211 01 Trial

Stay updated with breaking news from Bnt211 01 trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BNT211 With or Without CARVac Shows Early Activity in CLDN6+ R/R Advanced Solid Tumors

The Claudin-6–directed CAR T-cell therapy, BNT211, showed signs of clinical activity in patients with CLDN6-positive relapsed or refractory solid tumors. ....

Roche Genentech , Merck Serono , Iovance Bio , Asher Bio , Translational Immunotherapy Of Cancer At Leiden University , Bristol Myers Squibb , Leiden University , Instil Bio , Molecular Partners , Neogene Therapeutics , Third Rock Ventures , Sastra Cell , Carvac , Solid Tumors , Cart Cell Therapy , Bnt211 01 Trial ,